1Heather P.Whitley,Wesley Lindsey.Sex-based differences in drug activity[EB/OL].http://www.aafp.org/afp/2009/1201/p1254.html.
2The digitalis investigation group.The effect of digoxin on mortality and morbidity in patients with heart failure[EB/OL].http://content.nejm.org/cgi/content/abstract/336/8/525?ck=nck.
3Schwartz JB.The current state of knowledge on age,sex,and their interactions on clinical pharmacology[J].Clin Pharmacol Ther,2007,82(1):87-96.published at http://d.wanfangdata.com.cn/NSTLQK_NSTL_QK14597370.aspx.
8Kane JM, Leacht S, Carpenter D, et al. The expert consensus guideline series, optimizing pharmacolog- ic treatment of psychotic diaorders [J]. J Clin Psy- chiatry, 2003, 64 (Suppl 12 ): S21-S22.
9Feldman PD, Kaiser CJ, Kennedy JS, et al. Com- parison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years [J 1. J Clin Psychiatry, 2003, 64 ( 9 ) : 998 - 1004.
10Correll CU, Kishimoto T, Kane JM. Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives [J]. Dia- logues Clin Neurosci, 2011 ,13(2):155-172.
